Am J Gastroenterol

1. WILSON NJ, Mordan N, Potrock C, Shaheen NJ, et al
   Screening for Barrett Esophagus and Esophageal Adenocarcinoma: Approaches and Outcomes.
   Am J Gastroenterol. 2026;121:302-311.
   

   >> Share

   
   

   
   Am J Surg

2. JENSEN CB, Xie S, Sinha A, Bacon EM, et al
   Statewide episode spending variation of thyroidectomy for lower-risk thyroid cancer.
   Am J Surg. 2026;253:116816.
   

   >> Share

   
   

   
   Anticancer Res

3. IWASA YI, Hori K, Yokota Y, Kitoh R, et al
   Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study.
   Anticancer Res. 2026;46:1079-1087.
   

   >> Share

   
   

   
   BMC Cancer

4. WANG L, Li Y, Qiu T, Liu J, et al
   Improving prediction accuracy of radiation-induced temporal lobe injury in nasopharyngeal carcinoma using ADC-based deep learning and dosiomics.
   BMC Cancer. 2026 Jan 28. doi: 10.1186/s12885-026-15599.
   

   >> Share

   
   
5. SATHASIVAM HP, Japar R, Alias Z, Zakaria Z, et al
   Human papillomavirus (HPV) - driven head and neck squamous cell carcinoma (HNSCC) in a multi-ethnic developing country.
   BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15550.
   

   >> Share

   
   
6. LI H, Lou P, Huang Y, Ma J, et al
   Nomogram for predicting papillary thyroid carcinoma risk combined with clinical, biochemical and ultrasonographic indicators.
   BMC Cancer. 2026 Feb 5. doi: 10.1186/s12885-026-15686.
   

   >> Share

   
   

   
   BMC Surg

7. DONG S, Chen Z, Shui C, Liu T, et al
   Risk factors for transient hypoparathyroidism and hypocalcemia following total thyroidectomy with central lymph node dissection for papillary thyroid carcinoma: a single-center retrospective study.
   BMC Surg. 2026 Feb 3. doi: 10.1186/s12893-026-03516.
   

   >> Share

   
   
8. MAHDOOD B, Merajikhah A, Akbari Z, Bastami M, et al
   Surgical management and reconstruction techniques for divided eyelid nevus: a systematic review.
   BMC Surg. 2025;26:91.
   

   >> Share

   
   

   
   Clin Cancer Res

9. MICHAL M, Malik F, Mansour B, Hattery T, et al
   FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from PLAG1-Rearranged Adnexal and Salivary Gland Myoepithelial Tumors.
   Clin Cancer Res. 2026;32:628-644.
   

   >> Share

   
   

   
   Clin Nucl Med

10. VERMA P, Reddy MM, Lila A, Basu S, et al
    Localization of Parathyroid Adenoma With 68Ga-NODAGA-RGD PET/CT and Demonstration of "Metabolic Superscan" With Lincoln Sign and Costochondral Junction Beading: A Potential Clinical Application.
    Clin Nucl Med. 2025 Jun 5. doi: 10.1097/RLU.0000000000006013.
    

    >> Share

    
    
11. DENIZMEN ZORBA D, Isik EG, Arslan DF, Sen C, et al
    Enhancing Nasopharyngeal Cancer Follow-up: 68Ga-Trivehexin PET/CT for Distinguishing Recurrence From Infection.
    Clin Nucl Med. 2025 Jul 1. doi: 10.1097/RLU.0000000000006015.
    

    >> Share

    
    
12. ZHAO Q, Li Y, Zhao L
    FDG PET/CT in a Case of Tracheal Inflammatory Myofibroblastic Tumor.
    Clin Nucl Med. 2025 Aug 13. doi: 10.1097/RLU.0000000000006084.
    

    >> Share

    
    
13. DUTTA M, Jayanthi MR, G S, Haja A, et al
    Not All That Glows Is Cancer: Ga-68 FAPI PET/CT Uptake in Eosinophilic Esophagitis.
    Clin Nucl Med. 2025 Oct 16. doi: 10.1097/RLU.0000000000006164.
    

    >> Share

    
    
14. LEDER T, Freesmeyer M, Kuhnel C, Lorenz K, et al
    F-18-Ethylcholine-PET/Ultrasound Fusion Imaging for Detection of Occult Parathyroid Adenomas in Primary Hyperparathyroidism.
    Clin Nucl Med. 2025 Dec 9. doi: 10.1097/RLU.0000000000006269.
    

    >> Share

    
    
15. SEO M, Han MW, Park SH
    Thyroid-Shaped Iodine Uptake in the Scrotum: An Unusual Finding on 131I Whole-body Scan.
    Clin Nucl Med. 2025 Dec 18. doi: 10.1097/RLU.0000000000006282.
    

    >> Share

    
    
16. QUAK E, Catroux A, Lasne-Cardon A, Ciappuccini R, et al
    False-Positive Skin Uptake on 18F-Choline PET/CT Related to an Inflammatory Epidermoid Cyst in a Patient With Parathyroid Adenoma.
    Clin Nucl Med. 2025 Dec 22. doi: 10.1097/RLU.0000000000006291.
    

    >> Share

    
    
17. CHEN SH, Cheng NM, Fan KS, Chang PH, et al
    Refining M1-Stage Stratification in De Novo Metastatic Nasopharyngeal Carcinoma Using 18F-FDG PET/CT: Preliminary Evidence.
    Clin Nucl Med. 2026;51:195-202.
    

    >> Share

    
    
18. CUI Y, Wang Y, Du B, Li Y, et al
    A Rare Linitis Plastica Manifestation of Esophageal Squamous Cell Carcinoma With Diffuse Gastric Metastasis Revealed by 18F-FDG PET/CT.
    Clin Nucl Med. 2026;51:235-236.
    

    >> Share

    
    
19. ZHANG J, Dong A, Wang Y
    FDG PET/CT in a Case of Primary Tracheal ALK-Negative Anaplastic Large Cell Lymphoma.
    Clin Nucl Med. 2026;51:283-284.
    

    >> Share

    
    

    
    Dis Esophagus

20. HUANG JQ, Xiao HM, Ma CX, Wang RZ, et al
    Chemoradiotherapy with versus without concurrent immune checkpoint inhibitor for locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study.
    Dis Esophagus. 2026;39:doag007.
    

    >> Share

    
    
21. BLONK L, Straatman J, Wierdsma NJ, Gisbertz SS, et al
    Nutritional aspects and quality of life in gastroesophageal cancer patients that underwent colonic interposition.
    Dis Esophagus. 2026;39:doaf126.
    

    >> Share

    
    

    
    Gastrointest Endosc

22. INABA A, Kadota T, Nishihara K, Sato D, et al
    Long-term outcome after endoscopic submucosal dissection for entire circumferential cT1aN0M0 esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2026 Jan 29:S0016-5107(26)00073.
    

    >> Share

    
    

    
    Head Neck

23. WANG CC, Wang CC, Yang CC, Hwang TZ, et al
    Response to Letter to the Editor: Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2026 Jan 30. doi: 10.1002/hed.70173.
    

    >> Share

    
    
24. CUNHA MT, Hwang J, Bhateja P, Bonomi M, et al
    Comment on: Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2026 Jan 30. doi: 10.1002/hed.70175.
    

    >> Share

    
    

    
    Int J Cancer

25. DOEVE BH, Kuijper SC, Silversmit G, van Walle L, et al
    Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparison.
    Int J Cancer. 2025 Nov 19. doi: 10.1002/ijc.70225.
    

    >> Share

    
    
26. OUYANG YF, Liang JL, Xie RQ, Liu YP, et al
    The value of nasopharyngeal brush versus plasma EBV DNA detection in diagnosing local recurrence of nasopharyngeal carcinoma.
    Int J Cancer. 2026 Feb 3. doi: 10.1002/ijc.70357.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

27. CHEN L, Cohen M, Hatzglou V, Zhang Z, et al
    Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study).
    Int J Radiat Oncol Biol Phys. 2026;124:676-685.
    

    >> Share

    
    
28. KIM JK, Tam M, Kim SG, Solomon E, et al
    A Phase 2 Exploratory Trial Evaluating Computed Tomography-Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2026;124:662-675.
    

    >> Share

    
    

    
    J Clin Oncol

29. YE Z, Mojahed-Yazdi R, Zapaishchykova A, Tak D, et al
    Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma.
    J Clin Oncol. 2026;44:386-399.
    

    >> Share

    
    

    
    J Nucl Med

30. MARSH IR, Quon H, Santhanam P, Wang H, et al
    Combination Radiopharmaceutical Therapy and Radiotherapy for Thyroid Cancer: Dosimetry-Driven Precision Medicine.
    J Nucl Med. 2025 Dec 18:jnumed.120.253443. doi: 10.2967/jnumed.120.253443.
    

    >> Share

    
    

    
    J Oral Maxillofac Surg

31. OOMS M, Winnand P, Heitzer M, Bickenbach J, et al
    Is Intraoperative Flap Perfusion a Predictive Factor for Postoperative Flap Revision of Anterolateral Thigh Flaps and Fibula Free Flaps in Microvascular Head and Neck Reconstruction?
    J Oral Maxillofac Surg. 2026;84:270-278.
    

    >> Share

    
    
32. JIN S, He Y, Huo T, Xu F, et al
    A Novel Nomogram Based on the Fibrinogen and Platelet-to-Lymphocyte Ratio Is Associated With Overall Survival in Oral Squamous Cell Carcinoma.
    J Oral Maxillofac Surg. 2026;84:257-269.
    

    >> Share

    
    

    
    Laryngoscope

33. CURRY T, Wener E, Odell M, Caulley L, et al
    Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario.
    Laryngoscope. 2026 Feb 4. doi: 10.1002/lary.70410.
    

    >> Share

    
    

    
    Oral Oncol

34. WANG N, Gao H, Yu SX, Fan J, et al
    The first report of contralateral parapharyngeal space metastasis of papillary thyroid carcinoma: report of a case.
    Oral Oncol. 2026;174:107865.
    

    >> Share

    
    
35. HACK S, Karni RJ, Maniaci A, Fundakowski CE, et al
    Evaluation of large language models as decision support tools for head and neck cancer management: A blinded multidisciplinary simulation study.
    Oral Oncol. 2026;174:107877.
    

    >> Share

    
    
36. ROY P, Weber MB, Gupta R, Kakkar A, et al
    The prognostic significance of the 'Worst Pattern of Invasion' in oral cancers-an international collaborative multicentre analysis.
    Oral Oncol. 2026;174:107874.
    

    >> Share

    
    
37. ZHANG L
    Comment on "Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery".
    Oral Oncol. 2026;174:107881.
    

    >> Share

    
    
38. TRAC J, Ramchandani R, Dutta P, Sarkis L, et al
    Jaw-in-a-day (JIAD) for malignant indications: A systematic review.
    Oral Oncol. 2026;173:107823.
    

    >> Share

    
    
39. ZHANG W, Wu X, Wang Y, Le Q, et al
    Development and validation of a risk nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma.
    Oral Oncol. 2026;173:107842.
    

    >> Share

    
    
40. TAKAHASHI Y, Bell D, Corona A, Su SY, et al
    Establishment of novel stable human sinonasal NUT carcinoma cell lines.
    Oral Oncol. 2026;173:107828.
    

    >> Share

    
    
41. XING C, Xu S, Liu R, Wang Q, et al
    Predicting occult lymph node metastasis in level II using preoperative factors.
    Oral Oncol. 2026;173:107850.
    

    >> Share

    
    
42. HO AS, Luu M, Manzoor D, Maluf H, et al
    Incorporation of grade into stage in oral cavity squamous cell carcinoma: A novel staging schema.
    Oral Oncol. 2026;173:107847.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

43. CHEUNG MH, Kim CH, Nguyen SA, Williamson L, et al
    Oncologic Outcomes of Transoral Robotic Surgery in HPV-Associated OPSCC: A Systematic Review and Meta-Analysis.
    Otolaryngol Head Neck Surg. 2026;174:334-346.
    

    >> Share

    
    
44. PRINCE ADP, Schaaff C, Forner D, Oslin K, et al
    Perioperative Outcomes in Antegrade, Retrograde, and Extracapsular Approaches to Parotidectomy in Benign and Malignant Neoplasms.
    Otolaryngol Head Neck Surg. 2026;174:438-449.
    

    >> Share

    
    
45. FASSLER CA, Krishnapura SG, Sharbel D, Rosenthal E, et al
    Utility of a Novel Mobile Lip-Reading Application for Patients After Total Laryngectomy.
    Otolaryngol Head Neck Surg. 2026;174:582-586.
    

    >> Share

    
    
46. GIBBS HM, Sramek MT, Hintze JM, Vasudevan SS, et al
    Lymphoepithelial Carcinoma of the Salivary Gland: A Systematic Review and Single Institution Experience.
    Otolaryngol Head Neck Surg. 2026;174:297-304.
    

    >> Share

    
    
47. MA CC, Mannion K, Topf MC, Rohde SL, et al
    Intraoperative Identification and Stimulation of the Ansa Cervicalis Nerve Plexus.
    Otolaryngol Head Neck Surg. 2026;174:554-560.
    

    >> Share

    
    
48. TOBCU E, Karavas E, Yilmaz GT, Tobcu Z, et al
    Follow up or FNAB?: Malignancy Rates of ACR TI-RADS 4 and 5 Thyroid Nodules <10 mm in Diameter.
    Otolaryngol Head Neck Surg. 2026;174:366-374.
    

    >> Share

    
    
49. BARRAMEDA BN, Gogulapati A, Guo K, Squires L, et al
    Efficacy of Intraoperative Facial Nerve Monitoring in Parotidectomy: A Systematic Review and Meta-Analysis (1970-2025).
    Otolaryngol Head Neck Surg. 2026;174:291-296.
    

    >> Share

    
    
50. CLEMENTI EA, Timothee P, Charles-Obi K, Zhu C, et al
    Pediatric Head and Neck Chordomas: A National Analysis of Prognostic Indicators and Survival Outcomes.
    Otolaryngol Head Neck Surg. 2026;174:522-530.
    

    >> Share

    
    

    
    PLoS One

51. MASE T, Toyomasu Y, Ishinaga H, Nanpei Y, et al
    Prognostic role of interim F-18 fluorodeoxyglucose positron emission tomography-computed tomography during chemoradiation therapy in patients with hypopharyngeal squamous cell carcinoma.
    PLoS One. 2026;21:e0341189.
    

    >> Share

    
    
52. NGUYEN VB, Le TB, Van CL
    Single-session radiofrequency ablation for the treatment of benign cystic thyroid nodules: A prospective study.
    PLoS One. 2026;21:e0341556.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

53. TODEA RA, Kulcsar Z
    Defining Meaningful Apparent Diffusion Coefficient Change Using MR-Linac in Head and Neck Cancer.
    Radiol Imaging Cancer. 2026;8:e250783.
    

    >> Share

    
    
54. CHEN D, Wang W, Li Q, Rao X, et al
    Preoperative CT-based Radiomics for Predicting Response to Neoadjuvant Chemoimmunotherapy in Esophageal Squamous Cell Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250128.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share